ONA

ONA is a health app developed to support and monitor the quality of life of patients with T-cell acute lymphoblastic leukemia (T-ALL) participating in the European ALL-TARGET clinical trial. This trial is an academic initiative that aims to demonstrate the feasibility of a personalized medicine approach in patients with this type of leukemia. The app combines social support tools, symptom monitoring, and tracking of the patient's physical and emotional status through the use of specific questionnaires. Additionally, its extended version presents educational content validated by professionals, with the aim of improving understanding of the disease and promoting self-care. We hope that all of this will help improve the quality of life of these patients during the clinical trial. ONA is not available to the general public or to patients not included in this trial.